Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial

NACompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 17, 2024

Study Completion Date

May 26, 2024

Conditions
Breast Cancer
Interventions
DEVICE

Ice-Sense3TM/ ProSenseTM

Trial Locations (19)

10011

Mount Sinai Beth Israel, New York

10032

Columbia University/ NY Presbyterian hospital, New York

10065

Weill Cornell Medical College, New York

10467

Montefiore Medical Center, New York

19107

Thomas Jefferson University hospital, Philadelphia

30720

Dalton Surgical Group, Dalton

38138

West Clinic, Germantown

44106

University hospitals cleveland medical center, Cleveland

45227

Cincinnati Breast Surgeons Inc., Cincinnati

48085

Comprehensive Breast Care, Troy

48201

Karmanos Cancer Institute, Detroit

48507

Regional Medical Imaging, Flint

75075

Complete Breast Care, Plano

85306

Ironwood Cancer & Research Centers, Glendale

87114

Breast Specialty care/ Presbyterian Hospital, Albuquerque

92705

BreastLink, Santa Ana

06611

Bridgeport Hospital, Yale Medical School, Trumbull

46202-5116

Indiana University, Indianapolis

07728

CentraState Medical Center, Freehold

Sponsors
All Listed Sponsors
lead

IceCure Medical Ltd.

INDUSTRY